Page last updated: 2024-11-07

pk 14105

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

PK 14105: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122277
SCHEMBL ID2879654
MeSH IDM0145901

Synonyms (22)

Synonym
pk 14105
n-butan-2-yl-1-(2-fluoro-5-nitrophenyl)-n-methylisoquinoline-3-carboxamide
pk-14105
107257-28-3
tol0wgc9vu ,
1-(2-fluoro-5-nitrophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamide
unii-tol0wgc9vu
3-isoquinolinecarboxamide, 1-(2-fluoro-5-nitrophenyl)-n-methyl-n-(1-methylpropyl)-
SCHEMBL2879654
n-(sec-butyl)-1-(2-fluoro-5-nitrophenyl)-n-methylisoquinoline-3-carboxamide
HY-100346
CS-5669
pk14105
AKOS030228148
BCP10337
pk-14105;pk 14105
Q27290084
DTXSID80910274
n-(butan-2-yl)-1-(2-fluoro-5-nitrophenyl)-n-methylisoquinoline-3-carboxamide
AS-55972
n-methyl-n-(1-methyl-propyl)-1(2-fluoro-5-nitrophenyl)isoquinoline-3-carboxamide
AKOS040742425

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (25.00)18.7374
1990's20 (71.43)18.2507
2000's1 (3.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.39 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]